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RAPPORTDESYNTHèSE 
L'hyperémie réactive dans la microcirculation musculature et cutanée de l'avant-bras permet d'évaluer l'atteinte 
vasculaire dans les maladie cardiovasculaires. Cette méthode permet d'obtenir un reflet de la progression de 
l'atteinte vasculaire, de traquer la progression de la maladie ainsi que le risque cardio-vasculaires. Elle est en étude 
également pour tester l'efficacité d'une intervention thérapeutique. L'hyperémie réactive est dépendante d'une 
dilatation post ischémique par diminution des résistances artériolaires. Au niveau des membres, l'ischémie peut-être 
débutée et interrompue très facilement par une manchette à pression gonflée au-dessus de la pression systolique 
suivie quelqUes minutes plus tard de son dégonflement. Les mesures de flux sanguin musculaire et cutané au niveau 
d'un membre sont facile à réaliser chez l'homme, tout particulièrement au niveau de l'avant-bras. 
Pour l'instant aucune étude utilisant cette approche ne spécifiait quel avant-bras était utilisé. Il est cependant 
concevable que la réponse varie selon que l'on teste le bras dominant ou non-dominant. Il paraît donc important de 
clarifier ce point. Le premier but de l'étude consiste donc à investiguer une éventuelle différence entre le bras 
dominant et le bras non-dominant d'un sujet lors de tests de l'hyperémie réactive dans le muscle et la peau. 
Il est connu que l'hyperémie réactive au niveau musculaire peut-être diminuée par les médicaments 
antiinflammatoires non stéroïdiens (AINS), indiquant une implication partielle des métabolites de la cyclo-oxygénase. 
L'influence des AINS sur la réponse cutanée est moins clairement établie. Ainsi, le second but de cette étude est de 
comparer l'effet de l'inhibition de la cyclo-oxygénase sur l'hyperémie réactive musculaire et cutanée chez des sujets 
sains. 
Le collectif de patients consiste en 23 sujets masculins volontaires, en bonne santé, non fumeurs, de 18 à 30 ans. 
Aucuns antécédents médicaux ne sont connus et aucune médication n'est prise durant la période de l'étude. Tous 
les sujets ont donné leur consentement par écrit. Le flux sanguin muscÙlaire de l'avant-bras est mesuré au moyen 
d'une pléthysmographie par occlusion veineuse, et le flux cutané l'est par imagerie laser Doppler. 
Les expériences ont lieu entre 16 et 18 h dans une chambre calme à température constante (23-24 °C) chez un sujet 
couché. Les participants n'ont pas consommé d'AINS durant la semaine précédente ni bu de café dans les 12 h 
précédant l'expérience. 
Les mesures sont effectuées en triplicat au niveau musculaire puis cutané ou inversement selon un ordre aléatoire. 
Suite à une occlusion artérielle l'étude du flux se fait sur 3 min et 5 min de récupération sont prises entre 2 mesures. 
L'expérience 1 consiste à tester un possible effet systématique de la latéralisation du bras dominant ou non sur la 
réponse à l'hyperémie réactive dans la peau et le muscle de l'avant-bras. 16 sujets sont étudiés à 2 reprises, 
espacées de 1 à 3 jours. A la première visite, l'hyperémie musculaire est étudiée dans un avant-bras, la réaction 
cutanée dans l'autre et inversement lors de la deuxième visite. Une précaution est observée afin de mesurer le flux 
sanguin cutané à la même distance du poignet dans les 2 avant-bras. 
L'expérience 2 est développée pour évaluer l'impact d'une inhibition des cyclo-oxygénases. Sept sujet sont 
considérés à 2 occasions espacées de 7 à 10 j. L'étude s'effectue uniquement au niveau de l'avant-bras dominant. 
Le site cutané au niveau du poignet est marqué lors de la première visite afin d'utiliser le même site de mesure lors 
de la seconde visite. Le sujet ingère 1,8 g d'Aspegic (équivalant à 1 g d'acide acétylsalilcylique) dissout dans 125 ml 
de jus d'orange ou le jus d'orange seul lors de l'autre visite selon un ordre randomisé. Les mesures sont débutées 2 
h après la prise. 
Les résultats sont résumés selon 1) le pic d'augmentation du flux sanguin au-dessus de la valeur de base mesurée 
avant l'occlusion artérielle et 2) la durée de l'hyperémie calculée depuis le relâchement de l'occlusion artérielle 
jusqu'à une valeur d'augmentation du flux au-dessus de la ligne de base inférieur à 25% de la valeur au pic. La 
valeur du p est fixée à 0.05. Les données sont résumées selon une valeur moyenne ±dérivation standard. 
L'étude des résultats ayant rapport au premier but de l'étude démontre l'absence de différence systématique dans 
l'avant-bras dominant ou non-dominant lors d'une mesure de l'hyperémie réactive musculaire ou cutanée. 
Les résultats concernant le deuxième but de l'étude sont les suivants ; cette dose d'acétylsalicylate orale est 
suffisante pour diminuer la durée de la réponse hyperémique dans la peau mais pas pour réduire son pic maximal. 
Au niveau musculaire, le pic est statistiquement diminué mais pas la durée de la réponse. Cependant, la 
pléthysmographie pour une question purement pratique, ne permet pas de capturer les premières secondes de 
l'hyperémie et pourrait donc manquer le pic maximal, sachant que nos données considèrent le pic que 6 à 9 s après 
le dégonflement de la manchette à pression. Ainsi, nous ne pouvons pas prétendre évaluer l'impact d'un AINS sur le 
flux sanguin musculaire maximal post ischémique par la pléthysmographie. Ceci nécessite une autre méthodologie 
pour mesurer le flux sanguin musculaire. 
En résumé, nos données montrent que l'hyperémie réactive cutanée et musculaire ne diffère pas systématiquement 
entre le côté dominant ou non-dominant mais peuvent toutes 2 être diminuées par la prise d'acide acétylsalicylique. 
Ainsi ces méthodes d'évaluation des maladies cardiovasculaires peuvent être utilisées sans tenir compte du côté 
étudié mais l'influence des AINS est à prendre en considération. Toutefois cette dernière restriction ne s'applique pas 
aù pic de réponse au niveau cutané. 
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Summary 
Reactive hyperemia (RH) in forearm muscle or skin microcirculation 
has been considered as a surrogate endpoint in clinical studies of 
cardiovascular disease. We evaluated two potential confounders · 
that might limit such use of RH, namely laterality of measurement 
and intake of non-steroidal anti-inflammatory drugs (NSAIDS). 
Twenty-three young non-smoking healthy adults were enrolled. In 
Experiment 1 (n=16), the RH elicited by 3 min of ischemia was 
recorded in the muscle (strain gauge plethysmography, hand 
excluded) and skin (laser Doppler imaging) of both forearms. In 
Experiment 2 (n=h RH was determined in the dominant forearm 
only, one hour following oral acetylsalicylic acid (1 g) or placebo. In 
Experiment 1, peak RH was identical in both forearms, and so were 
the corresponding durations of responses. RH Jasted significantly 
Jess in muscle than in skin (p=0.003), a hitherto unrecognized fact. 
In the skin, acetylsalicylate reduced duration ( 43 vs. 57.4 s for 
placebo, p=0.03), without affecting the peak response. In muscle, 
duration tended to decrease with acetylsalicylate (21.4 vs. 26.0 s 
with placebo, p=0.06) and the peak increase in blood flow was 
blunted (27 .2 vs. 32.4 ml/min/100 ml tissue with placebo, 
p=0.003). We conclude that, when using RH as a surrogate 
endpoint in studies of cardiovascular disease, a confounding by 
laterality of measurement need not be feared, but NSAIDS may 
have an influence, although perhaps not on the peak response in 
the skin. 
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Introduction 
Cardiovascular diseases are presently a major 
cause of morbidity and death worldwide. Intervention 
trials focusing on so-called "hard" end-points, i.e. events 
such as an occurrence of stroke, acute myocardial 
infarction, newly diagnosed heart failure, or death are 
usually both extremely expensive and technically 
complicated, requiring the inclusion of huge number of 
patients observed over several years in order to achieve 
sufficient power (Williams 2005). In addition, it has been 
pointed out that the aforementioned endpoints lack bath 
specificity and sensitivity when evaluating the efficacy of 
potential new therapies or prevention strategies (Cohn 
2004). For these reasons, a substantial effort has been 
directed at identifying surrogate endpoints for 
cardiovascular disease, i.e. markers that would be linked 
to underlying pathophysiological events, thus reflecting 
disease progression and obviating the need to wait for the 
occurrence of clinical events, at least in trials designed to 
test for the efficacy of an intervention. 
Numerous surrogate endpoints have been 
proposed (Cohn et al. 2004, Mancini et al. 2004). For 
some invasive maneuvers are required, examples being 
the assessment of endothelial function from the 
vasodilation induced by an intra-arterial infusion of 
acetylcholine into the coronary or forearm circulation. 
Other surrogate endpoints are accessible non-invasively, 
such as flow-induced vasodilation of the brachial artery, 
or the carotid intima-media thickness ratio, which can 
bath be determined with ultrasonic techniques. The 
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assessment of such non-invasively available endpoints 
requires considerable technical skills and/or shows 
substantial operator dependence, which constitutes an 
obstacle to large scale usage in trials or epidemiological 
studies. One exception is the evaluation of reactive 
hyperemia, i.e. the trans1ent increase of blood flow above 
resting level observed after a short period of ischemia. 
Reactive hyperemia is dependent on the post-ischemic. 
dilation of resistance arterioles. It is easily assessed in 
limbs, where ischemia can be started and terminated very 
simply by the inflation above systolic pressure, followed 
a few minutes later by deflation of a proximally placed 
pneumatic cuff. In these conditions, limb blood flow can 
be measured serially with strain gauge plethysmography, 
a method that in the forearm essentially reflects perfusion 
to skeletal muscle if care is taken to exclude the hand 
circulation in the course of assessment. Alternatively, 
microvascular skin blood flow can be recorded at a site 
distal to the cuff with laser Doppler flowmetry. Both 
strain gauge plethysmography and laser Doppler 
flowmetry are noninvasive, do not require a high level of 
training, and produce results essentially independent of 
the operator. 
Whether assessed in forearm muscle (Sanada et 
al. 2002) or skin (Binggeli et al. 2003), reactive hypermia 
was diminished in hypercholesterolemic subjects in 
comparison with normocholesterolemic ones. In 862 
healthy women, Vuilleumier et al. (2002) found that the 
peak reactive hyperemic response in forearm skin was 
negatively correlated with the Framingham risk score. 
The duration of reactive hyperemia in foreram muscle 
decreased with the accumulation of risk factors in 449 
subjects devoid of overt cardiovascular disease (Ishibashi 
et al. 2006). Forearm skin reactive hyperemia was 
blunted in type 1 and type 2 diabetics (Tur et al. 1991, 
Skrha et al. 2001 ), and so was its muscle counterpart in 
patients with heart failure (Hirooka et al. 1994) or in 
those who later developed restenosis following coronary 
angioplasty (Wu et al. 2000). Taken together, these 
observations support reactive hyperemia as a potentially 
useful marker of cardiovascular disease. 
It is notew01thy that none of these clinical 
studies specified which forearm was used for assessing 
reactive hyperemia. At least in the muscular vascular bed, 
it is conceivable that the response could differ between 
the dominant and non-dominant arm. In 16 young healthy 
adults, Carlsson et al. (1987) found that muscular reactive 
hyperemia was on the average 20 % greater in the right 
than in the left forearm, but did not report whether any of 
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these subjects were left-handed. We were unable to locate 
any other study concerning the effects of laterality on 
forearm reactive hyperemia. It would be important to 
clear this methodological point if these vascular 
responses are to be used for investigational purposes. The 
first aim of the present study was therefore to investigate 
possible systematic differences between the dominant and 
non dominant forearm regarding reactive hyperemia in 
muscle and skin. 
It is lmown that forearm muscle reactive 
hyperemia in humans can be blunted by non steroidal 
antiinflammatory drugs (NSAID) (Kilbom and 
Wennmalm 1976, Carlsson and Wennmalm 1983, 
Carlsson et al. 1987, Engelke et al. 1996), indicating a 
partial dependence on metabolites of the cyclo-oxygenase 
(COX) pathway. Whether prostanoids also act as 
mediators of this response in human skin is less clear in 
view of contradictory reports indicating either no effect 
(Moppett et al. 2003, Dalle-Ave et al. 2004) or some 
inhibition by NSAIDs (Carlsson et al. 1983, Bisgaard et 
al. 1986, Binggeli et al. 2003). This point is relevant to 
the use of reactive hyperemia as a surrogate endpoint for 
cardiovascular disease, in view of the widespread intake 
of NSAIDs in the general population (Andersson et al. 
1999). Therefore, our second aim was to compare the. 
effects of COX inhibition on forearm skin and muscle 
reactive hyperemia in healthy humans. 
Methods 
Subjects 
A total of 23 lean male non-smoking volunteers 
aged 18-30 years were studied. Medical history was 
unremarkable in all, and none had been on any 
medication for the month preceding the investigation. 
Approval was obtained from our Institutional Review 
Board for Human Experimentation. All subjects · gave 
their informed consent in written. 
Reactive hyperemia 
A standard size pneumatic cuff was placed 
around the upper arm. Following baseline measurement 
of either skin or muscle blood flow in the corresponding 
forearm (see below for details of blood flow 
measurements), the upper arm cuffwas inflated for 3 min 
to a pressure of 200 mm Hg (i.e. largely above systolic), 
in order to achieve occlusion of aiterial inflow, and then 
deflated, by means of an EC20 rapid cuff inflator 
(Hokanson, Bellevue, W A, USA). 
2008 
Measurement offorearm muscle bloodflow 
The hand was excluded from the circulation by 
inflation above systolic pressure of a pediatric blood 
pressure cuff placed around the wrist. In such conditions, the 
arterial inflow to the forearm, as provided by venous 
occlusion strain gauge plethymography, essentially 
represents blood flow to skeletal muscle. Venous occlusion 
was accomplished by means of the upper arm cuff, again 
inflated with the EC20 inflator, to a pressure of 40 mmHg 
for 6 s. The rate of increase in forearm volume in the course 
of venous occlusion was measured with a mercury strain 
gauge (Hokanson No. 20 or 22, depending on foreatm size) 
conhected to a TLIOO plethysmograph (Hokanson). The 
generated analog signal was digitized with a Powerlab 
ML880 system (ADlnstruments, Spechbach, Germany), 
visualized online for quality control ( checking in patticular 
for the presence of cardiogenic oscillations, which are 
required for data validity) and stored on computer disk for 
later processing. The Powerlab system also controlled the 
rapid cuff inflator, such that venous occlusions took place at 
regular 12-s intervals, starting 6 s after release of arterial 
occlusion. Blood flow was expressed in ml per minute and 
per 100 ml of tissue volume. 
Measurem<mt offorearm skin bloodflow 
A laser Doppler Imager (LDI, Moor Instruments, 
Axminster, UK) was used to measure dermal blood flow 
within a 0.5x2 cm area of distal forearm skin (at 
approximately 5 cm from the wrist), as previously 
described in this laborat01y (Kubli et al. 2000, Pellaton et 
al. 2002, Boegli et al. 2003). Flow measurements, each 
lasting 2 s, were repeated at regular 5-s intervals, starting 
immediately after release of arterial occlusion. 
Erythrocyte flux was expressed in Perfusion Units (PU), 
as usual with laser Doppler flowmetry. 
Protocols 
The study was approved by the Institutional 
Review Board on Human Experimentation at the 
University of Lausanne. The participants gave their 
ihformed consent in written. They were asked to not to 
take any antiinflammat01y drugs in the week, and not to 
drink any coffee in the 12 h, which preceded the study. 
All experiments took place between 4 and 6 p.m., in a 
quiet, temperature-controlled room (23-24 °C), with the 
subject lying supine on a hospital bed. 
Timing of measurements 
In al! experiments~ measurements of post-
Reactive Hyperemia 687 
occlusive blood flow were carried out in triplicate in skin, 
and then in triplicate in muscle, or in the reversed order 
according to a randomization scheme. It was not feasible 
to simultaneously explore both territories, because small 
forearm movements generated by the repeated cuff 
inflations inherent to plethysmography would have 
interfered with laser Doppler flowmetry. Allowing for. 
5 min of restored blood flow before the next arterial 
occlusion (which lasted 3 min as stated above), one 
triplicate recording of reactive hyperemia in one territory 
took 25 min. 
Experiment 1 
This experiment was designed to test for a 
possible systematic effect of laterality on . the reactive 
hyperemic response of forearm skin and muscle. Sixteen 
subjects were studied on two occasions 1 to 3 days apart. 
On the first visit, muscle reactive hyperemia was 
recorded in one forearm, and skin muscle hyperemia in 
the other. Laterality of measurements was reversed on the 
second visit. Care was taken to assess skin blood flow at 
the same distance from the wrist on both forearms. 
Experiment 2 
This experiment was designed to evaluate the 
impact COX blockade on· the reactive hyperemic 
response of forearm skin and muscle. Seven subjects 
were studied on two occasions 7 to 10 days apart. 
Reactive hyperemia was assessed in the dominant 
forearm only. On the first visit, the exact location of the 
site for skin blood flow measurement was marked on a 
transparent acetate film, together with the anatomical 
outline of the forearm, taking care to precisely reproduce 
the position of the distal skin fold marking the limit of the 
wrist. In this way, the same skin site could be probed on 
the second visit, thus removing one source of 
experimental variation. 
The subject ingested 1.8 g of lysine 
acetylsalicylate (Aspegic®, equivalent to 1 g of 
acetylsalicylate) dissolved in 125 ml orange juice on one 
visit, and the same volume of orange juice alone on the 
other visit, in a randomized order. This dose of 
acetylsalicylate has been shown in our laboratory to block 
COX-dependent dermal microvascular vascular 
responses, with an efficiency maintained between 30 min 
and 2 h following administration (Golay et al. 2004). 
Skin and muscle reactive hyperemia were determined in 
triplicate within the second hour after ingestion. 
688 Addor et al. 
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Fig. 1. Time course of reactive hyperemia induced by 3 min of 
ischemia (dashed vertical lines) in skin and muscle, evaluated in 
the dominant and non-dominant arm of 16 healthy subjects. Data 
are means ± S.D. 
The time course of each reactive hyperemic 
response was summarized as 1) the peak increase of 
blood flow above the baseline value measured 
immediately before arterial occlusion, and 2) the duration 
of hyperemia, calculated from the release of arterial 
occlusion to the time when the increase of blood flow 
above baseline became less than 25 % of its peak value. 
No systematic effect the order ofmeasurement within one 
series of triplicate was apparent from the data. Therefore, 
values of parameters derived from individual reactive 
hyperemia were averaged within triplicates. Then, 
· statistical comparisons between responses obtained from 
the dominant and non-dominant arm (Experiment 1) or 
recorded after placebo and acetylsalicylate ingestion 
(Experiment 2) were carried out with paired t-tests, at an 
alpha level of0.05. Data were summarized as mean ± SD. 
Results 
Experiment 1 
The mean time courses of skin and muscle blood 
flow following 3 min of ischemia are shown in Figure 1. 
There were no differences between the dominant and 
non-dominant forearm. A striking feature was the much 
longer duration of reactive hyperemia in the skin as 
compared to the response in muscle. These visual 
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Fig. 2. Summary measures of reactive hyperemia induced by 
3 min of ischemia in skin and muscle, evaluated in the dominant 
and non-dominant arm of 16 healthy subjects. §§ p<0.01 duration 
in skin vs. duration in muscle. Data are means ± S.D. 
impressions conveyed by Figure 1 are quantified in 
Figure 2. The peak responses were practically identical in 
both forearms (muscle 27.8±2.2 and 28.3±6.0 ml/min/100 
ml tissue p=0.75, skin 272±50 and 249±55 perfusion 
units p=0.14, on respectively the dominant and non 
dominant sides), and so were the corresponding durations 
(muscle 24.8±'7.7 and 24.2±5.7 s, p=0.75, skin 54.1±22.4 
and 51.8±23.1 s, p=0.66). The difference in duration 
between reactive hyperemia in muscle and skin was 
highly significant (p = 0.003). 
Experiment 2 
Figure 3 depicts the mean time courses of 
reactive hyperemia in skin and muscle of the dominant 
forearm, following the ingestion of either 1 g 
acetylsalicylate or placebo, and the corresponding 
quantitations are shown in Figure 4. In the skin, COX 
blockade resulted in a somewhat shorter duration of 
hyperemia (acetylsalicylate 43.2 vs. placebo 57.4 s, 
p=0.03), without affecting the peak response 
(acetylsalicylate 286 vs. placebo 295 perfusion units, 
p=0.75). In forearm muscle, duration tended to decrease 
with acetylsalicylate (21.4 vs. 26.0 ·s with placebo, 
p=0.06) and the peak increase in blood flow was 
significantly blunted (27.2 vs. 32.4 ml/min/100 ml tissue 
2008 
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Fig. 3. Time course of reactive hyperemia induced by 3 min of 
ischemia (dashed vertical lines) in skin and muscle, evaluated in 
the dominant arm of 7 healthy subjects, following the ingestion 
of either placebo or acetylsalicylate (lg). Data are means ± S.D. 
with placebo, p=0.003). Again, the difference induration 
between reactive hyperemia in muscle and skin was 
significant (p=O.O 1 ), although not affected by 
acety lsalicylate. 
Discussion 
As a transient response of distal vascular beds 
upon relief of temporary ischemia, reactive hyperemia 
depends on multiple mechanisms. Metabolic factors, in 
the fonn of local accumulation and subsequent washout 
of vasodilator metabolites such as carbon dioxide, ADP 
or adenosine, are in all likelihood important, with 
supporting evidence ranging from response prolongation 
with increasing duration of ischemia to its partial 
inhibition by pharmacologie blockade of adenosine 
receptors (Carlsson et al. 1987). However, there is also 
strong experimental evidence for the importance of 
mechanical factors, acting in large part, although not 
exclusively via the eùdothelial release of vasodilator 
mediators (Ko lier and Kalley 1990b ), As recently 
described in details by Koller and Bagi (2002), such 
factors could include deformation of endothelial cells 
when arterioles collapse in the course of flow 
interruption, as well as their stimulation by stretch and 
shear stress when reperfusion occurs. Thus, reactive 
hyperemia might serve as a clinical index of endothelial 
function, an attractive concept because this vascular 
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Fig. 4. Summary measures of reactive hyperemia induced by 
3 min of ischemia. in skin and muscle, evaluated in the dominant 
arm of 7 healthy subjects, following the ingestion of either 
placebo or acetylsalicylate (1 g). * p<0.05, ** p<0.01 acetylsali-
cylate vs. placebo. §§ p<0.01 duration in skin vs. duration in 
muscle. Data are means ± S.D. 
response can be easily recorded non invasively with the 
methods used in the present paper. In accordance with 
this expectation, a tight correlation was found in a mixed 
population of hypertensive and healthy adults between 
peak reactive hyperemia in forearm muscle (measured 
with plethysmography) and the gold standard of 
endothelial function in humans, namely the response of 
forearm blood flow to the intrarterial infusion of 
acetylcholine) (Higashi et al. 2001). Considering this 
background and the intimate link between endothelial 
dysfunction and the pathogenesis of cardiovascular 
disease, it is consistent that reactive hyperemia can track 
disease progression and cardiovascular risk, as reviewed 
in the Introduction. 
In most of the relevant studies, reactive 
hyperemia was evaluated in a single forearm, without 
specification of subject handedness. It makes sense that 
vascular responses in the skin should be symmetrical, as 
we indeed verified (Figures 1 and 2), but this assumption 
is Jess straightforward in the case of muscle. Carlson et 
al. (1987) examined 16 healthy subjects of both sexes 
with plethysmography and found a greater total excess 
blood flow on the right than on the left forearm (8.5±1.4 
vs. 6.8±1.4 ml/100 ml tissue, p=0.043). In contrast, no 
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such difference was reported in a more ancient work 
(Patterson and Whelan 1955). In none of these two 
studies was handedness reported. Our results clearly 
indicate that muscular reactive hyperemia · do es not 
systematically differ between the dominant and non 
dominant forearm. 
A vailable studies have consistently found that 
reactive hyperemia, as evaluated in the forearm with 
strain gauge plethysmography, was blunted by 
pharmacological inhibition . of COX. In healthy 
volunteers, acute reductions in the peak response ranging 
from 20 to 30 % were reported following acute oral 
administration of indomethacin (1.25 mg/kg) (Kilbom 
and Wennmalm 1976, Nowak and Wennmalm 1979), 
ibuprofen (1.2 g) (Engelke et al. 1996), or acetylsalicylate 
(2x 30 mg/kg) (Carlsson et al. 1983). We essentially 
reproduced these findings, although the decrease of peak 
forearm muscle hyperemia observed with 1 g 
acetylsalicylate amounted to somewhat less (17 %, Fig. 
4) than the 30 % reported by Carlson et al. (1983), who 
used a much larger dose of the same drug. Thus, the dose 
of acetylsalicylate chosen in the. present study may not 
have been sufficient to exert a maximal effect on reactive 
hyperemia in forearm muscle. Nevertheless, we and 
others have previously shown that 1 g acetylsalicylate 
administered orally was able to completely abolish the 
prostanoid dependent vasodilation induced in the skin by 
local application of anodal current (Durand et al. 2002, 
Golay et al. 2004). In forearm skin, this dose of 
acetylsalicylate had no effect on peak reactive hyperemia 
but reduced its duration (Figures 3 and 4). This finding 
must be taken with some caution considering the limited 
number of subjects in Experiment 2. Nevertheless, it 
might reconcile apparently discordant results obtained by 
various authors who did not report the full time course of 
reactive hyperemia, as evaluated in forearm skin with 
laser Doppler flowmet1y. Moppet et al. (2003) described 
that the peak response was unaffected by either ibuprofen 
(800 mg) or rofecoxib (25 mg), but provided no 
information on the later time course. By contrast, while 
not reporting on the peak response, Bingelli et al. (2003) 
found a 25 % reduction by acetylsalicylate (1 g) of 
postischemic skin blood flow measured after 30-60 s of 
reperfusion. Similarly, another study describing a 
depression of skin reactive hyperemia following 
administration of indomethacin in fact only reports the 
area under curve of the response (Bisgaard et al. 1986). 
In finger skin, indomethacin (1.5 mg/kg) reduced peak 
reactive hyperemia, which however was measured with 
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finger plethysmography rather than with laser Doppler 
flowmetry, such that the first 15 s of the response were 
missed. Finally, our previous report (Dalle-Ave et al. 
2004) that acetylsalicylate did not affect skin reactive 
hyperemia may have been due to the lower dose used in 
that study (0.5 g) in comparison with the preserit one 
(1 g). 
It is an inherent limitation of plethysmography 
that it cannot capture the first few seconds of reactive 
. hyperemia, and therefore may miss the actual peak, as 
most likely occurred in the present study, considering that 
the apparent maximal blood flow always corresponded to 
the first data point, obtained between 6 and 9 s after the 
release of arterial occlusion (Figures 1 and 3). We 
therefore cannot infer the impact of acetylsalicylate 
treatment on the actual maximal post-ischemic muscle 
blood flow, and neither can any of the aforementioned 
studies. Whether this actual maximum is resistant to 
COX blockade, as appears to be. the case for peak reactive 
hyperemia in the skin, could only be resolved by using 
another methodology for the measurement of muscle 
blood flow. 
The mechanisms whlch underly the dependence 
of postischemic vasodilation on prostanoids remain 
incompletely defined. A non-exhaustive list of 
possibilities includes the hypoxie activation of 
phospholipase A2 and consequent release of arachidonic 
acid from various cell types (Gross et al. 2005), the 
receptor-mediated stimulation of endothelial COX by the 
ADP accumulated in the course of ischemia (Boeynaems 
and Galland 1983), and the non-receptor-mediated 
stimulation of the same enzyme by hemodynamic forces 
acting during reperfusion (Koller and Kalley 1990a, 
Koller et al. 1994). 
Reactive hyperemia elicited by 3 min of forearm 
ischemia consistently lasted much longer in skin than in 
muscle (Figures 1-4). To our knowledge, this fact has 
escaped attention so far, no other study having cairied 
out, as was done here, the concomitant evaluation in bath 
tissues of vascular responses to ischemia of identical 
durations. One - admittedly simplistic - explanation 
could be that the oxygen debt incurred .with 3 min of 
interrupted blood flow is less intense in muscle than it is 
in skin, due to the presence of myoglobin-bound oxygen 
in the former. 
In summary, our data show that forearm muscle 
and skin reactive hyperemia do not systematically differ 
between the dominant and non-dominant side, but may 
bath be blunted by acetylsalicylate. Thus, if these 
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responses are to be used as surrogate endpoints in studies Conflict of Interest 
of cardiovascular disease, confounding by laterality of There is no conflict of interest. 
measurement need not be feared, but the possible 
influence of non-steroidal anti-inflammatory drugs must Acknowledgements 
be taken into account. However, the latter restriction The study was supported by departmental funds. 
might not apply to the peak response in the skin. 
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